Published in Retina on June 26, 2013
Review of spectral domain enhanced depth imaging optical coherence tomography of tumors of the choroid. Indian J Ophthalmol (2015) 0.84
Design of efficient, broadband single-element (20-80 MHz) ultrasonic transducers for medical imaging applications. IEEE Trans Ultrason Ferroelectr Freq Control (2003) 5.19
Idiopathic macular telangiectasia. Arch Ophthalmol (2006) 3.51
Corticosteroids and central serous chorioretinopathy. Ophthalmology (2002) 3.37
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina (2006) 3.29
Extreme choroidal thinning in high myopia. Retina (2015) 3.23
Pachychoroid neovasculopathy. Retina (2015) 2.44
Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol (2010) 2.37
Epiretinal proliferation seen in association with lamellar macular holes: a distinct clinical entity. Retina (2014) 2.27
Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol (2009) 2.22
The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina (2011) 2.12
Multimodal imaging findings in retinal deep capillary ischemia. Retina (2014) 2.11
Comparison of ultrasonic and ophthalmoscopic evaluation of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus (2004) 2.11
The expanded spectrum of focal choroidal excavation. Arch Ophthalmol (2011) 2.11
Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina (2007) 2.09
Photoreceptor outer segment abnormalities as a cause of blind spot enlargement in acute zonal occult outer retinopathy-complex diseases. Am J Ophthalmol (2008) 2.08
Epithelial thickness in the normal cornea: three-dimensional display with Artemis very high-frequency digital ultrasound. J Refract Surg (2008) 2.02
Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina (2014) 2.02
High-resolution ultrasonic imaging of the posterior segment. Ophthalmology (2004) 2.00
The "pitchfork sign" a distinctive optical coherence tomography finding in inflammatory choroidal neovascularization. Retina (2013) 1.98
Vitelliform macular dystrophy. Ophthalmology (2006) 1.93
Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol (2008) 1.92
Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy. Retina (2009) 1.87
Fundus autofluorescence in patients with pseudoxanthoma elasticum. Ophthalmology (2006) 1.87
Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia. JAMA Ophthalmol (2013) 1.76
Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina (2010) 1.74
Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina (2007) 1.71
Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina (2002) 1.63
Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina (2002) 1.60
Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol (2008) 1.60
Stromal thickness in the normal cornea: three-dimensional display with artemis very high-frequency digital ultrasound. J Refract Surg (2009) 1.58
High-resolution optical coherence tomography findings in optic pit maculopathy. Retina (2010) 1.56
Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol (2009) 1.48
Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina (2007) 1.44
Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy. Ophthalmology (2010) 1.38
Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections. Ophthalmology (2011) 1.33
Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis. Retina (2009) 1.33
Triamcinolone-associated crystalline maculopathy. Arch Ophthalmol (2010) 1.31
Epithelial, stromal, and total corneal thickness in keratoconus: three-dimensional display with artemis very-high frequency digital ultrasound. J Refract Surg (2010) 1.27
Oral phosphate binders in the treatment of pseudoxanthoma elasticum. J Am Acad Dermatol (2005) 1.25
Multiple evanescent white dot syndrome. Arch Ophthalmol (2006) 1.25
Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. J Glaucoma (2012) 1.25
Probability model of the inaccuracy of residual stromal thickness prediction to reduce the risk of ectasia after LASIK part I: quantifying individual risk. J Refract Surg (2006) 1.25
OUTER RETINAL TUBULATION IN ADVANCED AGE-RELATED MACULAR DEGENERATION: Optical Coherence Tomographic Findings Correspond to Histology. Retina (2015) 1.24
Chirp-coded excitation imaging with a high-frequency ultrasound annular array. IEEE Trans Ultrason Ferroelectr Freq Control (2008) 1.23
Choroidal infarction following photodynamic therapy with verteporfin. Arch Ophthalmol (2005) 1.22
Pachychoroid pigment epitheliopathy. Retina (2013) 1.22
Outer retinal tubulation in degenerative retinal disorders. Retina (2013) 1.21
Probability model of the inaccuracy of residual stromal thickness prediction to reduce the risk of ectasia after LASIK part II: quantifying population risk. J Refract Surg (2006) 1.21
Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol (2008) 1.20
Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings. Retina (2012) 1.16
Measurement of choroidal perfusion and thickness following systemic sildenafil (Viagra(®) ). Acta Ophthalmol (2012) 1.16
Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Retina (2007) 1.15
Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina (2014) 1.15
Long-term follow-up of outer retinal tubulation documented by eye-tracked and en face spectral-domain optical coherence tomography. Arch Ophthalmol (2012) 1.15
"Treat and extend" dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation. Retina (2009) 1.13
Development of subretinal fibrosis after anti-VEGF treatment in neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging (2010) 1.12
Ultrasonic tissue characterization using 2-D spectrum analysis and its application in ocular tumor diagnosis. Med Phys (2004) 1.12
Multiple evanescent white dot syndrome in patients with multifocal choroiditis. Retina (2002) 1.11
Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration. Invest Ophthalmol Vis Sci (2013) 1.11
Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy. Retina (2013) 1.10
Review of retinal angiomatous proliferation or type 3 neovascularization. Retina (2008) 1.10
Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol (2002) 1.09
Multimodal fundus imaging of pseudoxanthoma elasticum. Retina (2011) 1.08
Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina (2012) 1.07
Redefining multifocal choroiditis and panuveitis and punctate inner choroidopathy through multimodal imaging. Retina (2013) 1.07
Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Retina (2015) 1.07
Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography. Am J Ophthalmol (2013) 1.05
Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina (2007) 1.04
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF TYPE 3 NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Retina (2015) 1.03
Multimodal imaging of optic disc drusen. Am J Ophthalmol (2013) 1.03
Retinitis pigmentosa and other dystrophies. Dev Ophthalmol (2010) 1.03
Peripheral polypoidal choroidal vasculopathy as a cause of peripheral exudative hemorrhagic chorioretinopathy: a report of 10 eyes. Retina (2013) 1.03
Photoacoustic-guided convergence of light through optically diffusive media. Opt Lett (2011) 1.02
Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina (2010) 1.02
Comparing functional and morphologic characteristics of lamellar macular holes with and without lamellar hole-associated epiretinal proliferation. Retina (2015) 1.02
Disappearance of drusen after rhegmatogenous retinal detachment. Retin Cases Brief Rep (2010) 1.02
High-frequency chirp ultrasound imaging with an annular array for ophthalmologic and small-animal imaging. Ultrasound Med Biol (2009) 1.02
Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab. Retina (2006) 1.02
Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography. Retina (2015) 1.01
The nature of focal areas of hyperfluorescence or hot spots imaged with indocyanine green angiography. Retina (2002) 1.00
Noninvasive in vivo detection of prognostic indicators for high-risk uveal melanoma: ultrasound parameter imaging. Ophthalmology (2004) 1.00
Bilateral Salzmann-like nodular corneal degeneration after laser in situ keratomileusis imaged with anterior segment optical coherence tomography and high-frequency ultrasound biomicroscopy. J Cataract Refract Surg (2009) 1.00
Multimodal fundus imaging in Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol (2010) 0.99
Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials. Am J Ophthalmol (2010) 0.98
Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. Arch Ophthalmol (2008) 0.98
Epithelial thickness profile changes induced by myopic LASIK as measured by Artemis very high-frequency digital ultrasound. J Refract Surg (2009) 0.97
Outer retinal abnormalities in acute macular neuroretinopathy. Retina (2011) 0.96
Central corneal thickness measured by the Orbscan II system, contact ultrasound pachymetry, and the Artemis 2 system. J Cataract Refract Surg (2008) 0.95
Epithelial thickness after hyperopic LASIK: three-dimensional display with Artemis very high-frequency digital ultrasound. J Refract Surg (2010) 0.95
An update on the pharmacotherapy of neovascular age-related macular degeneration. Expert Opin Pharmacother (2013) 0.94
Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy. Retina (2007) 0.94
Spectral-domain optical coherence tomography and fundus autofluorescence findings in a case of laser pointer-induced maculopathy. Retin Cases Brief Rep (2013) 0.94
Retrospective review of the efficacy of topical bromfenac (0.09%) as an adjunctive therapy for patients with neovascular age-related macular degeneration. Retina (2009) 0.94
Very high frequency ultrasound biometry of the anterior and posterior chamber diameter. J Refract Surg (2004) 0.93